The global BPH treatment market is expected to grow from USD 33,031.10 million in 2024 to USD 47,045.80 million by 2034, at a ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Dr. Niti Navanimitkul, MD, from the Urology Center at Bangkok Hospital Pattaya gave an informative presentation to the ...

Winter leads to an increased risk of problems related to the prostate gland in seniors. Cold weather causes urinary and ...

We are excited to reach this important milestone in the Expander-2 Pivotal Trial,” said Paul Edwards, President and CEO of Prodeon Medical. “Completing enrollment is a key step in our mission to ...

A MAN suffering from a common cancer was forced to have his entire penis amputated after it spread to his manhood, in what ...

People with obesity, as well as those with kidney or liver disease, are more likely to suffer with bad odour. Some medicines ...

Annual check-ups save lives by detecting prostate issues early, yet many men avoid these crucial tests due to fear or misconceptions. Prostate health ...